Literature DB >> 10951696

Oral immunization of mice with transgenic tomato fruit expressing respiratory syncytial virus-F protein induces a systemic immune response.

J S Sandhu1, S F Krasnyanski, L L Domier, S S Korban, M D Osadjan, D E Buetow.   

Abstract

Respiratory syncytial virus (RSV) is one of the most important pathogens of infancy and early childhood. Here a fruit-based edible subunit vaccine against RSV was developed by expressing the RSV fusion (F) protein gene in transgenic tomato plants. The F-gene was expressed in ripening tomato fruit under the control of the fruit-specific E8 promoter. Oral immunization of mice with ripe transgenic tomato fruits led to the induction of both serum and mucosal RSV-F specific antibodies. The ratio of immunoglobulin subclasses produced in response to immunization suggested that a type 1 T-helper cell immune response was preferentially induced. Serum antibodies showed an increased titer when the immunized mice were exposed to inactivated RSV antigen.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10951696     DOI: 10.1023/a:1008979525909

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  39 in total

Review 1.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

2.  Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice.

Authors:  H S Mason; J M Ball; J J Shi; X Jiang; M K Estes; C J Arntzen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

Review 3.  New vaccines against mucosal pathogens: rotavirus and respiratory syncytial virus.

Authors:  S E Coffin; P A Offit
Journal:  Adv Pediatr Infect Dis       Date:  1997

Review 4.  Prevention and treatment of respiratory syncytial virus infections (for advances in pediatric infectious diseases).

Authors:  J DeVincenzo
Journal:  Adv Pediatr Infect Dis       Date:  1997

5.  Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine.

Authors:  H W Kim; J G Canchola; C D Brandt; G Pyles; R M Chanock; K Jensen; R H Parrott
Journal:  Am J Epidemiol       Date:  1969-04       Impact factor: 4.897

Review 6.  Prospects for a respiratory syncytial virus vaccine.

Authors:  C B Hall
Journal:  Science       Date:  1994-09-02       Impact factor: 47.728

7.  Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity.

Authors:  R A Olmsted; N Elango; G A Prince; B R Murphy; P R Johnson; B Moss; R M Chanock; P L Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

8.  Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis.

Authors:  P A Piedra; S Grace; A Jewell; S Spinelli; D Bunting; D A Hogerman; F Malinoski; P W Hiatt
Journal:  Pediatr Infect Dis J       Date:  1996-01       Impact factor: 2.129

9.  Respiratory syncytial virus or influenza?

Authors:  D M Fleming; K W Cross
Journal:  Lancet       Date:  1993 Dec 18-25       Impact factor: 79.321

10.  The CaMV 35S enhancer contains at least two domains which can confer different developmental and tissue-specific expression patterns.

Authors:  P N Benfey; L Ren; N H Chua
Journal:  EMBO J       Date:  1989-08       Impact factor: 11.598

View more
  35 in total

1.  Oral immunogenicity of tomato-derived sDPT polypeptide containing Corynebacterium diphtheriae, Bordetella pertussis and Clostridium tetani exotoxin epitopes.

Authors:  Ruth E Soria-Guerra; Sergio Rosales-Mendoza; Leticia Moreno-Fierros; Rubén López-Revilla; Angel G Alpuche-Solís
Journal:  Plant Cell Rep       Date:  2010-12-25       Impact factor: 4.570

2.  Cholera toxin B protein in transgenic tomato fruit induces systemic immune response in mice.

Authors:  Xiao-Ling Jiang; Zhu-Mei He; Zhi-Qiang Peng; Yu Qi; Qing Chen; Shou-Yi Yu
Journal:  Transgenic Res       Date:  2007-01-16       Impact factor: 2.788

3.  Molecular evolution of the E8 promoter in tomato and some of its relative wild species.

Authors:  Lingxia Zhao; Liya Lu; Lida Zhang; Aoxue Wang; Ning Wang; Zhuobin Liang; Xiaowen Lu; Kexuan Tang
Journal:  J Biosci       Date:  2009-03       Impact factor: 1.826

4.  Uniform accumulation of recombinant miraculin protein in transgenic tomato fruit using a fruit-ripening-specific E8 promoter.

Authors:  Tadayoshi Hirai; You-Wang Kim; Kazuhisa Kato; Kyoko Hiwasa-Tanase; Hiroshi Ezura
Journal:  Transgenic Res       Date:  2011-02-27       Impact factor: 2.788

Review 5.  Novel vaccine development strategies for inducing mucosal immunity.

Authors:  Yoshiko Fujkuyama; Daisuke Tokuhara; Kosuke Kataoka; Rebekah S Gilbert; Jerry R McGhee; Yoshikazu Yuki; Hiroshi Kiyono; Kohtaro Fujihashi
Journal:  Expert Rev Vaccines       Date:  2012-03       Impact factor: 5.217

6.  Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination.

Authors:  Tomonori Nochi; Hidenori Takagi; Yoshikazu Yuki; Lijun Yang; Takehiro Masumura; Mio Mejima; Ushio Nakanishi; Akiko Matsumura; Akihiro Uozumi; Takachika Hiroi; Shigeto Morita; Kunisuke Tanaka; Fumio Takaiwa; Hiroshi Kiyono
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-15       Impact factor: 11.205

7.  Tomato (Lycopersicon esculentum) prevents lead-induced testicular toxicity.

Authors:  Emmanuel O Salawu; Olusola A Adeeyo; Olutunde P Falokun; Uthman A Yusuf; Abiodun Oyerinde; Anthony A Adeleke
Journal:  J Hum Reprod Sci       Date:  2009-01

8.  Assessment of the utility of the tomato fruit-specific E8 promoter for driving vaccine antigen expression.

Authors:  Zhu-Mei He; Xiao-Ling Jiang; Yu Qi; Di-Qing Luo
Journal:  Genetica       Date:  2007-09-05       Impact factor: 1.082

Review 9.  Plant-based oral vaccines: results of human trials.

Authors:  C O Tacket
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

Review 10.  Plant-made vaccine antigens and biopharmaceuticals.

Authors:  Henry Daniell; Nameirakpam D Singh; Hugh Mason; Stephen J Streatfield
Journal:  Trends Plant Sci       Date:  2009-10-14       Impact factor: 18.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.